Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase

Abstract It is widely accepted that Hepatitis A virus (HAV) is responsible for liver failure and even death in older people and in people with other serious health issues; so, proposing new compounds with inhibitory activity can help to treated of these disease’s. In current study, a new class of qu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mehrnaz Rafiei Jorshari, Manouchehr Mamaghani, Parivash Jahanshahi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/10b4b0d8e8cf4f0f8b0868bdd550fddf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:10b4b0d8e8cf4f0f8b0868bdd550fddf
record_format dspace
spelling oai:doaj.org-article:10b4b0d8e8cf4f0f8b0868bdd550fddf2021-12-02T18:48:02ZSynthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase10.1038/s41598-021-98529-02045-2322https://doaj.org/article/10b4b0d8e8cf4f0f8b0868bdd550fddf2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98529-0https://doaj.org/toc/2045-2322Abstract It is widely accepted that Hepatitis A virus (HAV) is responsible for liver failure and even death in older people and in people with other serious health issues; so, proposing new compounds with inhibitory activity can help to treated of these disease’s. In current study, a new class of quinolines is proposed with inhibitor activity of the HAV proteinase. So, in the first step, fused quinoline derivatives has been synthesized in short reaction time (12.0 min) and high efficiency yields (94%) in presence of 1-carboxymethyl-2,3-dimethylimidazolium iodide ([cmdmim]I) ionic liquid catalyst using a new method. In the following, chemical reactivity and inhibitory activity of synthesized quinolines were evaluated in density functional theory (DFT) framework and molecular docking methodologies. High global softness (0.67 eV), low HOMOSWBNNT-LUMO4a gap (4.78 eV), and more negative adsorption energy (− 87.9 kJ mol−1) in these quinolines reveal that the 4a and 4b compounds have better delivery than other quinolines using SWBNNT as suitable carrier to target cells. Molecular docking shows that the best cavity of the HAV has − 134.2 kJ mol−1 interaction energy involving bonding and non-bonding interactions. In fact, these interactions are between fused quinolines with especial geometries and sidechain flexibility amino acids residues inside the best binding site of the HAV, as hydrogen bonding, steric, and electrostatic interactions. So, these interactions imply that proposed fused quinolines have good inhibitor activity for the HAV.Mehrnaz Rafiei JorshariManouchehr MamaghaniParivash JahanshahiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mehrnaz Rafiei Jorshari
Manouchehr Mamaghani
Parivash Jahanshahi
Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
description Abstract It is widely accepted that Hepatitis A virus (HAV) is responsible for liver failure and even death in older people and in people with other serious health issues; so, proposing new compounds with inhibitory activity can help to treated of these disease’s. In current study, a new class of quinolines is proposed with inhibitor activity of the HAV proteinase. So, in the first step, fused quinoline derivatives has been synthesized in short reaction time (12.0 min) and high efficiency yields (94%) in presence of 1-carboxymethyl-2,3-dimethylimidazolium iodide ([cmdmim]I) ionic liquid catalyst using a new method. In the following, chemical reactivity and inhibitory activity of synthesized quinolines were evaluated in density functional theory (DFT) framework and molecular docking methodologies. High global softness (0.67 eV), low HOMOSWBNNT-LUMO4a gap (4.78 eV), and more negative adsorption energy (− 87.9 kJ mol−1) in these quinolines reveal that the 4a and 4b compounds have better delivery than other quinolines using SWBNNT as suitable carrier to target cells. Molecular docking shows that the best cavity of the HAV has − 134.2 kJ mol−1 interaction energy involving bonding and non-bonding interactions. In fact, these interactions are between fused quinolines with especial geometries and sidechain flexibility amino acids residues inside the best binding site of the HAV, as hydrogen bonding, steric, and electrostatic interactions. So, these interactions imply that proposed fused quinolines have good inhibitor activity for the HAV.
format article
author Mehrnaz Rafiei Jorshari
Manouchehr Mamaghani
Parivash Jahanshahi
author_facet Mehrnaz Rafiei Jorshari
Manouchehr Mamaghani
Parivash Jahanshahi
author_sort Mehrnaz Rafiei Jorshari
title Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
title_short Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
title_full Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
title_fullStr Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
title_full_unstemmed Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
title_sort synthesis, delivery, and molecular docking of fused quinolines as inhibitor of hepatitis a virus 3c proteinase
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/10b4b0d8e8cf4f0f8b0868bdd550fddf
work_keys_str_mv AT mehrnazrafieijorshari synthesisdeliveryandmoleculardockingoffusedquinolinesasinhibitorofhepatitisavirus3cproteinase
AT manouchehrmamaghani synthesisdeliveryandmoleculardockingoffusedquinolinesasinhibitorofhepatitisavirus3cproteinase
AT parivashjahanshahi synthesisdeliveryandmoleculardockingoffusedquinolinesasinhibitorofhepatitisavirus3cproteinase
_version_ 1718377605346885632